In 2023, James C. Foster earned $2.68M in total compensation at Charles River Laboratories, including $1.48M salary and $1.13M bonus. Most recently sold 25,000 shares in Aug 2024. Currently holds stock worth $44.29M. Has donated $38.99M in stock to charitable causes. 8+ years at the helm of Charles River Laboratories.
Compensation History
Annual executive compensation data for James C. Foster, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$2.68M
Salary
$1.48M
Bonus
$1.13M
Other
$71.89K
Salary
$1.48MBoard Justification
The compensation program aims to attract and retain top talent while aligning executive interests with shareholder value, focusing on performance-based incentives.
Bonus
$1.13MBoard Justification
The annual cash incentive award is based on performance metrics including revenue and operating income, with a maximum payout of 200% of target based on performance against these metrics for fiscal year 2023.
Other Compensation
$71.89KBoard Justification
Includes various benefits such as life insurance, home security expenses, telecommuting benefits, and executive medical expenses.
Restricted Stock
Board Justification
No stock grants were vested in 2023 as the focus is on performance share units (PSUs) and stock options which have not yet vested.
Performance Metrics
Performance metrics for the cash bonus include revenue and operating income targets.
James C. Foster
CEO of Charles River Laboratories
Field of Expertise
Healthcare & Life Sciences - Life Sciences
Sector of Economy
Healthcare
CEO of Charles River Laboratories for
8 years 11 months (Jan 2017 - Present)
Previous Experience
Extensive experience in the life sciences sector, previously served as President of Charles River Laboratories.
Other Charles River Laboratories CEOs
Holdings
Track James C. Foster's stock holdings and portfolio value over time.
Total Stock Sold
$236.11M
$236.11M
2,622,826 CRL shares
What if they kept their stock?
If James C. Foster didn't sell their stock, today they would have:
Extra CRL2,622,826 shares worth $482.70M.
This is 104.44% and $246.59M more than what they got when they sold the stock.
Charitable Transactions
211,862 shares
CRL
Recent Charitable Transactions
2,500 shares
CRL
Aug 12, 2024
Charity
4,000 shares
CRL
Feb 16, 2024
Charity
2,500 shares
CRL
Aug 10, 2023
Charity
7,623 shares
CRL
May 15, 2023
Charity
2,000 shares
CRL
Jun 6, 2022
Charity
14,813 shares
CRL
Oct 26, 2021
Charity
Insider Trading
James C. Foster's recent stock transactions, purchases, and sales filed with the SEC.
2,500 shares
CRL
Aug 12, 2024
Charity
$6.25M
CRL at $250.00/share
Aug 1, 2024
Sale
4,000 shares
CRL
Feb 16, 2024
Charity
23,741 shares
CRL
Jan 29, 2024
Received
24,253 shares
CRL
Jan 29, 2024
Received
$1.00M
CRL at $178.05/share
Nov 14, 2023
Purchase
2,500 shares
CRL
Aug 10, 2023
Charity
7,623 shares
CRL
May 15, 2023
Charity
$5.00M
CRL at $250.08/share
Feb 15, 2023
Sale
49,725 shares
CRL
Jun 6, 2022
Received
Rivals
Compare James C. Foster with competitor CEOs and industry peers.